Does EZETIMIBE\ROSUVASTATIN Cause Off label use? 8 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Off label use have been filed in association with EZETIMIBE\ROSUVASTATIN. This represents 2.4% of all adverse event reports for EZETIMIBE\ROSUVASTATIN.
8
Reports of Off label use with EZETIMIBE\ROSUVASTATIN
2.4%
of all EZETIMIBE\ROSUVASTATIN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Off label use From EZETIMIBE\ROSUVASTATIN?
Of the 8 reports, 1 (12.5%) required hospitalization, and 3 (37.5%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EZETIMIBE\ROSUVASTATIN. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does EZETIMIBE\ROSUVASTATIN Cause?
Myalgia (58)
Acute kidney injury (24)
Arthralgia (17)
Blood creatine phosphokinase increased (17)
Leriche syndrome (16)
Muscle spasms (16)
Peripheral arterial occlusive disease (16)
Asthenia (14)
Drug abuse (14)
Hepatic cytolysis (12)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which EZETIMIBE\ROSUVASTATIN Alternatives Have Lower Off label use Risk?
EZETIMIBE\ROSUVASTATIN vs EZETIMIBE\SIMVASTATIN
EZETIMIBE\ROSUVASTATIN vs EZOGABINE
EZETIMIBE\ROSUVASTATIN vs FACTOR XIII CONCENTRATE
EZETIMIBE\ROSUVASTATIN vs FAM-TRASTUZUMAB DERUXTECAN-NXKI
EZETIMIBE\ROSUVASTATIN vs FAMCICLOVIR